Aim: The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid
Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal …

Subarachnoid hemorrhage (SAH) has a high mortality rate and causes long-term disability
in many patients, often associated with cognitive impairment. However, the pathogenesis of …

Puerarin was shown to exert anti-oxidative and anti-ferroptosis effects in multiple diseases.
The goal of this study was to explore the neuroprotective effect of puerarin on early brain …

Ferroptosis is a regulated cell death that characterizes the lethal lipid peroxidation and iron
overload, which may contribute to early brain injury (EBI) pathogenesis after subarachnoid …

Over the last two decades, neurological researchers have uncovered many
pathophysiological mechanisms associated with subarachnoid haemorrhage (SAH), with …

Background Oxidative stress is a crucial factor leading to subarachnoid hemorrhage (SAH)-
induced early brain injury (EBI). Isoliquiritigenin has been verified as a powerful anti-oxidant …

Subarachnoid hemorrhage (SAH) is a severe type of stroke featuring exceptionally high rate
of morbidity and mortality due to the lack of effective management. Ferroptosis can be …

Spontaneous subarachnoid hemorrhage (SAH) accounts for 5-10% of all strokes and is a
subtype of hemorrhagic stroke that places a heavy burden on health care. Despite great …

Bexarotene, a retinoid X receptor (RXR) agonist, is approved by FDA to treat cutaneous T-
cell lymphoma. However, it has also demonstrated promising therapeutic potential for …

Accurate stroke assessment and consequent favorable clinical outcomes rely on the early
identification and quantification of aneurysmal subarachnoid hemorrhage (aSAH) in non …